{
  "id": 2661251,
  "title": "Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700",
  "url": "https://urgent.news/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares-2661251",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-22T21:22:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/filings/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares-for-usd575-700/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "Cytokinetics CEO Robert Blum recently sold 7,500 shares of the company's stock, valued at $575,700, according to a recent SEC Form 4 filing. The transaction, which took place on August 10, 2026, saw the shares sold at a weighted average price of $76.76 per share, with a post-transaction market value of $77.49 per share. Cytokinetics, a clinical-stage biopharmaceutical company with a market capitalization of $10.6 billion, is developing innovative cardiac therapeutics using its proprietary muscle modulation platform. The company has already achieved commercial success with MYQORZO and maintains a pipeline of muscle-targeted candidates aimed at addressing significant unmet medical needs in cardiology.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Yahoo Finance",
        "title": "Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700",
        "url": "https://urgent.news/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares",
        "published": "2026-08-22T21:42:01.000Z"
      },
      {
        "outlet": "Nasdaq Markets",
        "title": "Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700",
        "url": "https://urgent.news/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares-2662826",
        "published": "2026-08-22T21:42:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}